Nucala 100 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FKEHF
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,929
Award facts
- Contract value 100% obligated
- $18,929.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,929.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of NUCALA 100 mg/ml syringes. The contract utilizes a firm fixed-price structure with an ultimate completion date of June 20, 2025. This delivery order was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the federal procurement market based on its established capabilities as a certified woman-owned small business.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $499,999,999 and effective through November 2026. The parent IDC enables the DLA to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables for Department of Defense healthcare facilities worldwide. NUCALA, a biologic injection used in the treatment of severe asthma, represents a specialized pharmaceutical product within the contract's extensive portfolio. DMS Pharmaceutical Group's status as a critical supplier in the federal pharmaceutical supply chain is evidenced by its consistent award of delivery orders across diverse medical product categories supporting military health operations.
Quick answers
Who was awarded contract SPE2DB25FKEHF?
SPE2DB25FKEHF was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 18, 2025.
How much is contract SPE2DB25FKEHF worth?
The government has obligated $18,929 on SPE2DB25FKEHF.
Is contract SPE2DB25FKEHF an order under another contract?
Yes. SPE2DB25FKEHF is a delivery order under SPE2DB24D9223, an indefinite delivery contract.
Was contract SPE2DB25FKEHF competed?
The extent of competition for SPE2DB25FKEHF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award